ROIVRoivant SciencesHealth Care
$35.44EarningsNov 9, 2026
1D—1W—1M—3M—1Y—
Market cap$25.5BCompany infoRevenue$7.5M52-wk range$15 – $42IndustryBiotechnologyWebsiteroivant.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +134.7% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E———
P / S3391.4×00
121
3387
P / FCF———
EV / EBITDA———
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin81.2%9385
68%
97%
Operating margin-18140.9%01
-18141%
8098%
Net margin-3534.9%01
-6080%
8445%
ROE-6.1%920
-103%
127%
ROIC-25.5%27
-57%
81%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.009693
0.0
0.5
Net debt / EBITDA———
Current ratio16.729899
Interest coverage999.0×9695
Per shareTTM, with year-over-year change
Revenue / share$0.01▼ −68%
EPS (diluted)$-0.44▲ +37%
FCF / share$-1.13▲ +5%
Est. EPS growth (fwd)—